Mike Hollan

The Upscript Health CEO discusses trends in telehealth for the coming year.

The molecule is an investigational pre-clinical oral GLP-1 receptor agonist.

PharmaLex’s chief strategy officer discusses strategies to improve monetization for these drugs.

Margaret Keegan, the new CEO of Precision Medicine Group, is eager to elevate the profile of the expert-rich service provider and build it into an industry leader in next-gen drug development and commercialization support.

Unleashed demand over the past year characterizes the M&A picture in pharma.

Regulatory, technological, and other factors are set to have a significant impact in the coming year.

This will bring Nimble’s psoriasis and inflammatory bowel disease treatment under AbbVie’s pipeline.

With the Inflation Reduction Act now in flux, how will the government and industry respond?

The swell of AI-powered digital platforms puts future decision-making under the spotlight.

Eli Lilly and Boehringer Ingelheim are also participating in the campaign, which will feature a float in the 2024 Rose Parade.

In the second part of this roundtable discussion, experts discuss how the industry is handling AI in the marketing space.

The two organizations are promoting education and the importance of screenings.

AI provides opportunities to bring people together—not replace them.

The industry is facing an uncertain regulatory landscape in the coming year.

This acquisition will bring Aliada’s Alzheimer’s treatment under AbbVie’s pipeline.

The report details the experiences of Hispanic, Black, and Asian patients.

Both firms were heavily focused on pharma and healthcare marketing during the previous year.

The actress is participating in the campaign for its third year.

The videos are designed to help bring people together during the holidays.

In this first part of this roundtable discussion, experts discuss the current perception of AI and how this is impacting adoption.

The report gives high rankings to brands from Pfizer and AstraZeneca.

EVERSANA’s chief digital officer discusses the current relationship between pharma and AI.

The musician launched the Get Low #2 campaign.

The non-profit’s new CEO discusses her role and how she plans to steer the organization towards the future.

The devices are being provided based on a variety of health-based features that they provide.

AIX exchanged key assets in exchange for ownership shares.

The two companies will work to develop treatments for SBMA.

CelloType produces more accurate results when analyzing high content tissue images.

The educational platform is targeted at HCPs and their staff.

The actor is part of a campaign for early colon cancer screening.